Stephen Kent to RNA, Messenger
This is a "connection" page, showing publications Stephen Kent has written about RNA, Messenger.
Connection Strength
0.692
-
PEG-free Lipid Nanoparticles for mRNA Delivery: Superhydrophilic Sulfoxide Polymer Coatings. Biomacromolecules. 2026 Jan 12; 27(1):624-639.
Score: 0.148
-
Influence of hydrophilic polymers on the accelerated blood clearance of mRNA lipid nanoparticles upon repeated administration. Nanoscale Horiz. 2025 Nov 17; 10(12):3396-3404.
Score: 0.148
-
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans. ACS Nano. 2024 10 01; 18(39):27077-27089.
Score: 0.136
-
Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm. 2024 Nov 15; 665:124695.
Score: 0.136
-
Age-related differences in mRNA vaccine immunogenicity and adjuvancy. Immunol Cell Biol. 2026 Apr; 104(4):400-414.
Score: 0.038
-
Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses. EBioMedicine. 2026 Jan; 123:106087.
Score: 0.037
-
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021 09 01; 131:16-40.
Score: 0.027
-
Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection. EBioMedicine. 2017 May; 19:119-127.
Score: 0.020